Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
March 15, 2024
The Department of Justice Announces a New Program to Pay Financial Rewards to Whistleblowers for Information About Corporate Crimes
February 23, 2024
UK: Trends and Developments
February 20, 2024
FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials
March 21, 2024
David Tetrick, Ben Watson, Darren Shuler, Lauren Smith and Jeanne Fugate counsel Molina Healthcare before a California federal court
March 6, 2024
Ursula Henninger Inducted Into American College of Trial Lawyers
February 26, 2024
Trial Partner Veronica Moyé Joins King & Spalding as Firm Opens New Office in Dallas